Please assess the completion status of the following clinical trial:

Trial Title: Vertebroplasty In The Treatment Of Acute Fracture Trial - The VITTA Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Presence of:~* at least one and at most two acute VCF (\< 6 weeks) at levels caudate to T4, confirmed with physical examination and radiographic imaging~* if timing of the fracture is unclear, the following criteria are required for inclusion in the trial~  1. an MRI scan showing edema at the fracture level(s) or~ 2. a bone scan showing increased uptake~* Physical examination showing axial back pain likely secondary to the VCF with restricted mobilization (score not maximum on any one of the following Barthel's Index items: transfer, mobility, bathing, dressing, stairs and toilet use)~* French or English speaking patient willing to return for follow-up or capable of following up with phone interviews if needed~Exclusion Criteria:~* Recent (\<30 days) major surgery causing debilitating pain~* Coagulopathy or thrombocytopenia precluding interventional treatment~* Inability to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Percutaneous vertebroplasty (PV) (Type: EXPERIMENTAL): The procedure involves percutaneous application of bone cement (polymethylmethacrylate) into collapsed vertebrae.
- Facet block (Type: ACTIVE_COMPARATOR): injection of anti-inflammatory and analgesic drugs

Based on this trial design, predict the completion outcome and termination type (if applicable).